DT Capital-Backed Tiansheng Pharma Completes IPO With $986M Valuation
May 19, 2017 — 14:53 CST
This Data Is Locked!
This area is available only to Subscribers.
Tiansheng Pharmaceutical Group Co., Ltd., a Chinese drug maker backed by local private equity firms DT Capital Partners and Leading Capital, has completed an initial... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals